These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10561012)
1. Current treatment of follicular low-grade lymphomas. Peterson BA Semin Oncol; 1999 Oct; 26(5 Suppl 14):2-11. PubMed ID: 10561012 [TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
3. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma: a therapeutic update. Italiano A; Thyss A Bull Cancer; 2005 Oct; 92(10):E57-64. PubMed ID: 16266867 [TBL] [Abstract][Full Text] [Related]
5. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic advances for indolent lymphomas]. Ogura M Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147 [TBL] [Abstract][Full Text] [Related]
8. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]. Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539 [TBL] [Abstract][Full Text] [Related]
9. Recombinant interferon-alpha therapy in patients with follicular lymphoma. Ozer H; Wiernik PH; Giles F; Tendler C Cancer; 1998 May; 82(10):1821-30. PubMed ID: 9587113 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas. Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762 [TBL] [Abstract][Full Text] [Related]
16. The role of mitoxantrone in the treatment of indolent lymphomas. Hagemeister F; Cabanillas F; Coleman M; Gregory SA; Zinzani PL Oncologist; 2005 Feb; 10(2):150-9. PubMed ID: 15709217 [TBL] [Abstract][Full Text] [Related]
17. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma. Laport GG Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587 [TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group. Witzig TE; Vukov AM; Habermann TM; Geyer S; Kurtin PJ; Friedenberg WR; White WL; Chalchal HI; Flynn PJ; Fitch TR; Welker DA J Clin Oncol; 2005 Feb; 23(6):1103-8. PubMed ID: 15657404 [TBL] [Abstract][Full Text] [Related]
19. High-dose therapy and transplantation in non-Hodgkin's lymphoma. Morrison VA; Peterson BA Semin Oncol; 1999 Feb; 26(1):84-98. PubMed ID: 10073565 [TBL] [Abstract][Full Text] [Related]
20. Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival. Turturro F Expert Rev Anticancer Ther; 2007 Jul; 7(7):959-65. PubMed ID: 17627454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]